Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; University of California San Diego School of Medicine, La Jolla, San Diego, CA, USA.
Hum Immunol. 2024 May;85(3):110770. doi: 10.1016/j.humimm.2024.110770. Epub 2024 Mar 2.
Post-acute sequelae of COVID-19 (PASC), or Long COVID, is a chronic condition following acute SARS-CoV-2 infection. Symptoms include exertion fatigue, respiratory issues, myalgia, and neurological manifestations such as 'brain fog,' posing concern for their debilitating nature and potential role in other neurological disorders. However, the underlying potential pathogenic mechanisms of the neurological complications of PASC is largely unknown. Herein, we investigated differences in antigen-specific T cell responses from the peripheral blood towards SARS-CoV-2, latent viruses, or neuronal antigens in 14 PASC individuals with neurological manifestations (PASC-N) versus 22 individuals fully recovered from COVID-19. We employed Activation Induced Marker (AIM), ICS and FluoroSpot assays to determine the specificity and magnitude of CD4 and CD8 T cell responses towards SARS-CoV-2 (Spike and rest of proteome), latent viruses (CMV, EBV), and several neuronal antigens. Overall, we observed similar antigen-specific T cell frequencies and cytokine effector T cell responses between PASC donors compared to recovered controls for all antigens tested (viral or autoantigen) in both CD4 and CD8 T cell compartments. Our findings suggest that PASC-N does not appear to be associated with changes in antigen-specific T cell responses towards a subset of disease-relevant targets, but more studies in a larger cohort are needed to confirm these unaltered responses.
新冠病毒感染后出现的长期后遗症(PASC),又称“长新冠”,是急性 SARS-CoV-2 感染后的一种慢性疾病。其症状包括劳累后疲劳、呼吸问题、肌肉疼痛和神经表现,如“脑雾”,这令人担忧其虚弱的性质和在其他神经障碍中的潜在作用。然而,PASC 神经并发症的潜在发病机制在很大程度上是未知的。在此,我们研究了 14 名有神经表现的 PASC 个体(PASC-N)与 22 名从 COVID-19 中完全康复的个体的外周血针对 SARS-CoV-2、潜伏病毒或神经元抗原的抗原特异性 T 细胞反应的差异。我们采用活化诱导标记物(AIM)、ICS 和 FluoroSpot 测定法来确定针对 SARS-CoV-2(Spike 和其余蛋白质组)、潜伏病毒(CMV、EBV)和几种神经元抗原的 CD4 和 CD8 T 细胞反应的特异性和强度。总体而言,与恢复期对照组相比,PASC 供体针对所有测试抗原(病毒或自身抗原)的 CD4 和 CD8 T 细胞中,针对 SARS-CoV-2 的抗原特异性 T 细胞频率和细胞因子效应 T 细胞反应相似。我们的研究结果表明,PASC-N 似乎与针对一组疾病相关靶标的抗原特异性 T 细胞反应的变化无关,但需要更多更大队列的研究来证实这些未改变的反应。